Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines

Link permanente della pagina
www.swissmedic.ch/out-of-stock-covid19-en

Status as of 01.12.2022

In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.

Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.

The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The goods are usually allocated and information provided on their respective availability by the department at the Federal Office of Public Health responsible for procuring medical goods.

Distribution period ongoing

Active substance	Pharmaceutical form / Dosage	Batch reference	Distribution licensed until
Casirivimab / Imdevimab	Concentrato per soluzione per infusione, 120mg/mL	N7601B04	30.06.2023
Propofol	Emulsion for injection/infusion, 10 mg/ml (in a pre-filled syringe)	RY659	30.06.2023
Sufentanil / Sufentanil citrate	Solution for injection, 0.05mg/ml (10x5 ml)	9D7B	31.05.2023
Remifentanil	Powder for preparation of a solution for infusion, 1mg	2G3L FM7M	30.04.2022
Propofol	Emulsione iniettabile/infusione, 10 mg/ml (iniettabile in una siringa preriempita)	RV189 SA835	28.02.2023
Cisatracurium	Solution for injection	LX3K	31.01.2023
Casirivimab / Imdevimab	Concentrate for solution for infusion 120mg/mL	N7546B01	31.12.2022
Propofol	Emulsion for injection	K20001A K20005A K20005B	31.12.2022
Propofol	Emulsione iniettabile/infusione, 10 mg/ml, 50ml flaconi	K20018B	31.12.2022
Cisatracurium	Solution for injection	7S6J	30.12.2022
Propofol	Emulsione iniettabile/infusione, 20 mg/ml (iniettabile in una siringa preriempita)	RL694 RP429 RT769	30.12.2022

Distribution period elapsed: products may still be present at the dispensing outlets; dispensing and use permitted until the batches have expired

Active substance	Pharmaceutical form / Dosage	Batch reference	Distribution licensed until
Propofol	Emulsion for injection/infusion, 20 mg/ml (in a pre-filled syringe)	RW409	30.11.2022
Sufentanil / Sufentanil citrate	Solution for injection, 0.005mg/ml (10x10 ml)	KY3H R49N	30.11.2022
Remdesivir	Powder for preparation of a solution for infusion, 100 mg	C2000141D2 20410871D1 00009D 00009D4 00010D2 20411011M AP0083BM1 AP0425BM1	25.11.2022
Sotrovimab	Concentrate for solution for infusion	UK3F-2	30.09.2022
Propofol	Emulsion for injection/infusion, 20 mg/ml, 50ml vials	T21018B	31.08.2022
Remifentanil	Powder for preparation of a solution for infusion, 5 mg	50PEH013	30.04.2022
Remifentanil	Powder for preparation of a solution for infusion, 1 mg	50PDH010	30.04.2022
Propofol	Emulsion for infusion 2 % MCT	16PD7549	31.12.2021
Propofol	20 mg/ml (50 ml emulsion for injection in a pre-filled syringe)	RM659	31.12.2021
Remifentanil	Powder for preparation of a solution for infusion, 5 mg	D38B	31.12.2021
Sufentanil / Sufentanil citrate	Solution for injection, 0.005mg/ml (5 x 2 ml)	MU9A	29.10.2021
Sufentanil / Sufentanil citrate	Solution for injection, 0.005mg/ml (10 x 10 ml)	JG9W	29.10.2021
Sufentanil / Sufentanil citrate	Solution for injection, 0.05 mg/ml (10 x 5 ml)	HG2B	29.10.2021
Sufentanil / Sufentanil citrate	Solution for injection, 0.005 mg/ml (5 x 10 ml)	BG4B	29.10.2021
Propofol	Emulsion for injection/infusion, 10 mg/ml	20K001A 20K001B 20K002A 20K002B 20K003A 20K003B	31.08.2021
Haemagglutininum influenzae A (H1N1) (H3N2) Haemagglutininum influenzae B (Victoria) (Yamagata)	Suspension for injection	X47	30.06.2021
Voriconazol	Powder for preparation of a solution for infusion, 200 mg	6452099	30.06.2021
Dexamethasone	Tablets, 4 mg	285120C	30.06.2021
Haemagglutininum influenzae A (H1N1) Haemagglutininum influenzae A (H3N2) Haemagglutininum influenzae B	Suspension for injection	7132B1A	30.04.2021
Rocuronium	Solution for injection 50 mg/5 ml	T012764	31.01.2021
Hydroxychloroquine	Lactab, 200mg	IYZ019 001- IYZ019 007	31.12.2020
Propofol	Emulsion for injection/infusion, 10 mg/ml	V19A013A V19A013B V19A013C	31.12.2020
Lopinavir / Ritonavir	Film-coated tablets, 200 mg/tab. and 50 mg/tab.	1125683 1125601 1126558	31.12.2020
Lopinavir / Ritonavir	Syrup, 400 mg/5 ml and 100 mg/5 ml	6088208 6088549	31.12.2020
Rocuronium	Solution for injection 50 mg/5 ml	T007003	31.12.2020
Propofol	Emulsion for injection and infusion, 10 mg/ml	10PC9969 16PB6740	31.12.2020
Hydroxychloroquine	Film-coated tablets, 200 mg	JM2447	31.12.2020
Lopinavir / Ritonavir	Tablets, 200 mg/50 mg	E200320	31.12.2020
Midazolam	Ampoules, 50 mg/10 ml	F1038F08 F1048F02	31.12.2020
Midazolam	Ampoules, 50 mg/10 ml	F1058F02	31.12.2020
Atazanavir	Capsules, 200 mg	ABH6626	30.11.2020
Amoxicillin / Clavulanic acid	2g/200 mg, powder for preparation of a solution for injection or infusion	KS3429	30.11.2020
Posaconazole	Gastro-resistant tablet, 100 mg	T001796 T001390	01.11.2020
Amoxicillin / Clavulanic acid	2g/200 mg, powder for preparation of a solution for injection or infusion	KS3426 KS3427	30.10.2020
Budesonide / Formoterol	Powder for inhalation, 100 µg/6 µg	LATU	31.08.2020
Budesonide / Formoterol	Powder for inhalation, 100 µg/6 µg	SLGV	31.08.2020
Erythromycin	Powder for solution for infusion, 1 g	01124TB23	31.07.2020
Solution for haemodialysis and haemofiltration	Sodium 140 mmol/l Potassium 4 mmol/l Magnesium 0.75 mmol/l Chloride 122 mmol/l Hydrogen phosphate 1 mmol/l Hydrogen carbonate 22 mmol/l / 1000 ml	19G0415 19K0610	30.06.2020